ReviewCurrent treatment options in cardiovascular medicine2018
Robotic-Assisted Percutaneous Coronary Intervention.
Review in Current treatment options in cardiovascular medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Safety and efficacy of robotic-assisted versus manual percutaneous coronary intervention: a systematic review and updated meta-analysis.Systematic reviews · 2025Pooled it
- Guideline of the Brazilian Society of Cardiology on Telemedicine in Cardiology - 2019.Arquivos brasileiros de cardiologia · 2019Guideline
- [Master manipulator of vascular intervention surgical robot based on haptic feedback].Sheng wu yi xue gong cheng xue za zhi = Journal of biomedical engineering = Shengwu yixue gongchengxue zazhi · 2026Article
- Multi-mode information fusion navigation system for robot-assisted vascular interventional surgery.BMC surgery · 2023Article
- Technical and Clinical Progress on Robot-Assisted Endovascular Interventions: A Review.Micromachines · 2023Review
- Cardiac X-ray image-based haptic guidance for robot-assisted coronary intervention: a feasibility study.International journal of computer assisted radiology and surgery · 2022Article
- An Isomorphic Interactive Device for the Interventional Surgical Robot after In Vivo Study.Micromachines · 2022Article
- Robotic-assisted intervention strategy to minimize air exposure during the procedure: a case report of myocardial infarction and COVID-19.Cardiovascular diagnosis and therapy · 2020Article
- Cath Lab Robotics: Paradigm Change in Interventional Cardiology?Current cardiology reports · 2019Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purpose of reviewThe goal of this review is to describe the benefits and limitations of robotic-assisted percutaneous coronary intervention (PCI), the most important and recent clinical data, and the future applications as robotic technology continues to develop. RECENT
findingsRobotic-assisted PCI can reduce occupational hazards of ionizing radiation exposure and orthopedic injury to the interventional cardiologist while offering increased precision and fine control that may confer benefit to the patient. Recent studies have suggested the efficacy and safety of robotic-assisted PCI, yet widespread use of the technology has not been fully adopted due to limitations of the current technology and high costs. Robotic-assisted PCI has potential to benefit both the operator and the patient. Despite some limitations of robotic-assisted PCI, it can safely and effectively be used in many patients with coronary artery disease requiring PCI. The value proposition for robotic-assisted PCI will depend on the evolution of robotic systems and its applicability to more complex coronary lesions, peripheral arterial interventions, and telemedicine.
Indexed as
Identifiers
29478224What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.